Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic plus zinc for secondary prophylaxis of hepatic encephalopathy in cirrhosis
IRCT20170609034406N9Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of zinc in hepatic encephalopathy (HE), decompensated cirrhosis and Cirrhosis, sponsored by Tabriz University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
zinc
03
Conditions
hepatic encephalopathy (HE)decompensated cirrhosisCirrhosis
Beyond the preview
Go deeper on IRCT20170609034406N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170609034406N9.